tbuckley/cabot-search huggingface dataset:
PS01.05: Early and Persistent Oligoclonal T Cell Expansion Correlates with Durable Response to Anti-PD1 Therapy in NSCLC
Authors: Sope Olugbile, Kazuma Kiyotani, Jae-Hyun Park, Philip Hoffman, Livia Szeto, Jyoti Patel, Everett Vokes, Yusuke Nakamura
Journal: Journal of Thoracic Oncology (2016)
TCT-285 Ten year follow-up results of left main percutaneous coronary intervention in elderly patients
Authors: Ignacio Sanchez-Perez, Jesus Piqueras-Flores, Fernando Lozano, María Thiscal López Lluva, Natalia Pinilla-Echeverri, Manuel Marina-Breysse, Andrea Moreno-Arciniegas, Alfonso Jurado
Journal: Journal of the American College of Cardiology (2016)
Altered Naive and Memory T Cell Homeostasis and Immunosenescence Characterize Younger Patients with Immunosuppressive-Responsive Myelodysplastic Syndrome
Authors: JianXiang Zou, Dana E Rollison, David Boulware, Elaine M. Sloand, Loretta Pfannes, Fanqi Bai, Jeffrey S. Painter, Sheng Wei, Denise Cosgrove, Alan F. List, P.K. Epling-Burnette
Journal: Blood (2008)
Comprehensive Comparison Of Gene Expression, Genomic DNA Methylation, and In Vitro Hematopoietic Differentiation Among Many Human iPS and ES Cell Lines
Authors: Masatoshi Nishizawa, Kazuhisa Chonabayashi, Akiko Oishi, Ikue Takei, Misato Nishikawa, Yoko Morioka, Akifumi Takaori-Kondo, Shinya Yamanaka, Yoshinori Yoshida
Journal: Blood (2013)
USE: EXPERIENCIA DE UN CENTRO MÉDICO EN BARCELONA
Authors: O Diaz-Canel Fernandez, P Gonçalves Da Cunha, LE Yip Baldeón, J Suárez Teran, M Blasi Puig, E Jauregui Juarez, Á Isava Tirado, X Ribot Molinet, R Duran Bermejo, J Merlo Mas
Journal: Endoscopy (2016)

La USE es una técnica segura, con escasas complicaciones, que permite estudio detallado y realización de PAAF de múltiples enfermedades digestivas.
TCT-803 Long term outcomes in diabetic patients treated with atherectomy for peripheral artery disease
Authors: Adam Janas, Piotr Buszman, Krzysztof Milewski, Marek Król, Wojciech Fil, Wojtek Wojakowski, Przemek Nowakowski, Aleksandra Blachut, Maciej Pruski, Pawel Buszman, R. Stefan Kiesz
Journal: Journal of the American College of Cardiology (2016)
The Comparison of Allogeneic Stem Cell Transplantation From Family-Mismatched/Haploidentical Donors with Unrelated Donors in Adults with High-Risk Acute Myeloid Leukemia,
Authors: Byung-Sik Cho, Heeje Kim, Jae-Ho Yoon, Seung-Hwan Shin, Seung-Ah Yahng, Sung-Eun Lee, Ki-Seong Eom, Yoo-Jin Kim, Seok Lee, Chang-Ki Min, Seok-Goo Cho, Dong-Wook Kim, Jong-Wook Lee, Woo-Sung Min, Chong-Won Park
Journal: Blood (2011)
“Yoga project in Oncology: observational study of the Yoga effects in cancer patient. The Poliambulanza experience”
Authors: F. Andreis, N. Liborio, F. Meriggi, C. Codignola, R. Anna, P. Bertocchi, F. Aroldi, C. Abeni, C. Ogliosi, L. Rota, T. Prochilo, B. Di Biasi, M. Mirandola, A. Zaniboni
Journal: Annals of Oncology (2015)
CIRUGÍA URGENTE VS. PRÓTESIS COLÓNICA COMO PUENTE A LA CIRUGÍA EN LA OBSTRUCCIÓN INTESTINAL DE TUMORES DE COLON IZQUIERDO: ESTUDIO COMPARATIVO DE UN CENTRO EN LOS ÚLTIMOS 7 AÑOS
Authors: A López Baz, B Alvarez Suarez, L Dorado, E Martí, A Dacal, D Tardáguila, A Lancho, A González Ramírez, O Maseda, L López Rosés
Journal: Endoscopy (2016)

Introducción: La obstrucción intestinal como debut del cáncer colorrectal se ha tratado tradicionalmente con intervención quirúrgica urgente. La colocación de prótesis de colon como puente a la cirugía es una alternativa. No obstante, algunos estudios han planteado dudas relacionadas con su seguridad y eficacia.
Comparison of baseline quality of life between minority and non-minority patients participating in oncology clinical trials
Authors: A. D. Tan, P. J. Novotny, J. S. Kaur, J. C. Buckner, P. L. Schaefer, P. J. Stella, J. A. Sloan
Journal: Journal of Clinical Oncology (2006)

8527 Background: Minority patients (MP) suffer deficits in access to care and socioeconomic status. This study uses a patient-level pooled analysis to explore whether these deficits translate into quality of life (QOL) differences between MP and non-MP on clinical trials. Method: Baseline QOL scores were combined from 47 clinical trials (6,513 patients) conducted either at the Mayo Clinic Cancer Center or in the North Central Cancer Treatment Group. QOL scales used were the Uniscale, Linear Analogue Self Assessment (LASA), Symptom Distress Scale (SDS), Profile of Mood States (POMS) and Functional Assessment of Cancer Therapy - General (Fact-G). Fisher’s Exact tests and linear regression adjusted for age, site, and performance score. Survival data was compared using the method of Kaplan-Meier. Results: Eight percent (531) of patients self-reported as MP (0.45% American Indian/Alaskan Native, 0.7% Asian, 5% Black/African American, 1.5% Hispanic, 0.1% Native Hawaiian and 0.3% Other). MP had no meaningful deficits in overall QOL or the SDS and were slightly worse on FACT-G total score, physical, social/family, functional, and SDS nausea severity. MP among lung cancer patients reported greater nausea (58 vs 69) and sleep problems (34 vs 54), with neurological cancers reported worse emotional well-being (53 vs 74), and with GI tumors had lower social/family well-being (60 vs 67). Regression models confirmed these results. Median survival time was shorter for MP (198 vs 310 days, p=0.001) but was not significant after adjusting for disease severity. Conclusions: MP on these clinical trials did not report large QOL deficits at baseline relative to non-MP. MP did indicate small deficits in physical, social, and emotional subscales. MP experienced large tumor-specific deficits for a few QOL domains that might bear further attention. [Table: see text] No significant financial relationships to disclose.
"ATYPICAL" CORONARY DISEASE IN YOUNG PEOPLE
Authors: Joseph Weinstein
Journal: Annals of Internal Medicine (1944)

Excerpt The title "Atypical Coronary Disease" was selected advisedly, since the term coronary disease has long been used synonymously with coronary sclerosis (atheromatous). In this sense, disease of the coronary arteries on any other basis would be atypical. Our interest in atypical changes in the vascular system as affecting the coronary vessels was stimulated by a series of 10 cases observed at the Station Hospital, Fort Ord, California over a three month period. None of the patients died, so that in the absence of autopsy investigations, one can, at best, only postulate as to the pathology or its etiologic basis. CASE
R-Ras Regulates Hematopoietic Stem/Progenitor Cell Adhesion, Migration, and Mobilization through Rac GTPase-Mediated Signals.
Authors: Xun Shang, Lina Li, Jose Concelas, Fukun Guo, Deidre Daria, Hartmut Geiger, Nancy Ratner, Yi Zheng
Journal: Blood (2007)
TCT-561 Long-Term Vascular Response to Permanent Polymer Everolimus-Eluting Stent vs. Biodegradable Polymer Biolimus-Eluting Stent: Five-year Follow-up Optical Coherence Tomography Study
Authors: Shoichi Kuramitsu, Shinjo Sonoda, hiroyuki jinnouchi, Yoshitaka Muraoka, Takenori Domei, Shinichi Shirai, Kenji Ando
Journal: Journal of the American College of Cardiology (2016)
Broad Spectrum Tumor Antigen-Specific Cytotoxic T Lymphocytes (CTL) for Therapy of Hematological Malignancy.
Authors: Ulrike Gerdemann, Anne S. Christin, Conrad Russell Cruz, Carlos A. Ramos, Donald R. Shaffer, Stephen Gottschalk, Helen E. Heslop, Malcolm K. Brenner, Catherine M. Bollard, Cliona M. Rooney, Ann M. Leen
Journal: Blood (2009)
Linguistic Strategies for Improving Informed Consent in Clinical Trials Among Low Health Literacy Patients
Authors: Janice L. Krieger, Jordan M. Neil, Yulia A. Strekalova, Melanie A. Sarge
Journal: JNCI Journal of the National Cancer Institute (2016)

Background: Improving informed consent to participate in randomized clinical trials (RCTs) is a key challenge in cancer communication. The current study examines strategies for enhancing randomization comprehension among patients with diverse levels of health literacy and identifies cognitive and affective predictors of intentions to participate in cancer RCTs. Methods: Using a post-test-only experimental design, cancer patients (n = 500) were randomly assigned to receive one of three message conditions for explaining randomization (ie, plain language condition, gambling metaphor, benign metaphor) or a control message. All statistical tests were two-sided. Results: Health literacy was a statistically significant moderator of randomization comprehension (P = .03). Among participants with the lowest levels of health literacy, the benign metaphor resulted in greater comprehension of randomization as compared with plain language (P = .04) and control (P = .004) messages. Among participants with the highest levels of health literacy, the gambling metaphor resulted in greater randomization comprehension as compared with the benign metaphor (P = .04). A serial mediation model showed a statistically significant negative indirect effect of comprehension on behavioral intention through personal relevance of RCTs and anxiety associated with participation in RCTs (P < .001). Conclusions: The effectiveness of metaphors for explaining randomization depends on health literacy, with a benign metaphor being particularly effective for patients at the lower end of the health literacy spectrum. The theoretical model demonstrates the cognitive and affective predictors of behavioral intention to participate in cancer RCTs and offers guidance on how future research should employ communication strategies to improve the informed consent processes.
Trapping of oxidized LDL in lysosomes of Kupffer cells as a trigger for hepatic inflammation
Authors: Sofie Walenbergh, Veerle Bieghs, Tim Hendrikx, Patrick van Gorp, Fons Verheyen, Marten H. Hofker, Ad A. Masclee, Ger H. Koek, Christoph J. Binder, Ronit Shiri-Sverdlov
Journal: Hepatology (2012)
TCT-201 Incidence and Implications of Presentation With Ventricular Tachycardia or Fibrillation in Patients With STEMI Undergoing Primary PCI: The HORIZONS-AMI Trial
Authors: Monica Embacher, Ioanna Kosmidou, Jose Dizon, Bjorn Redfors, Rushad Dordi, Roxana Mehran, Ori Ben-Yehuda, Gregg Stone
Journal: Journal of the American College of Cardiology (2016)
Very large treatment effects in randomised trials as an empirical marker to indicate whether subsequent trials are necessary: meta-epidemiological assessment
Authors: Myura Nagendran, Tiago V Pereira, Grace Kiew, Douglas G Altman, Mahiben Maruthappu, John P A Ioannidis, Peter McCulloch
Journal: BMJ (2016)

<b>Objective</b>&nbsp;To examine whether a very large effect (VLE; defined as a relative risk of ≤0.2 or ≥5) in a randomised trial could be an empirical marker that subsequent trials are unnecessary. <b>Design</b>&nbsp;Meta-epidemiological assessment of existing published data on randomised trials. <b>Data sources</b>&nbsp;Cochrane Database of Systematic Reviews (2010, issue 7) with data on subsequent large trials updated to 2015, issue 12. <b>Eligibility criteria</b>&nbsp;All binary outcome forest plots were selected, which contained an index randomised trial with a VLE that was nominally statistically significant (P&lt;0.05), included a subsequent large randomised trial (≥200 events and ≥200 non-events) for validation of the effect, assessed a primary outcome of the review, and was not a subgroup or sensitivity analysis. <b>Results</b>&nbsp;Of 3082 reviews yielding 85 002 forest plots, only 44 (0.05%) satisfied the inclusion criteria. Index trials were generally small, with a median sample of 99 (median 14 events). Few index trials were rated at low risk of bias (9 of 44; 20%). The relative risk was closer to the null in the subsequent large trials in 43 of 44 cases. Subsequent large trial data failed to find a statistically significant (P&lt;0.05) effect in the same direction in 19 cases (43%, 95% confidence interval 29% to 58%). Even when the subsequent large trials did find a significant effect in the same direction, the additional primary outcomes in most of these trials would have to be considered before deciding in favour of using the intervention. Subsequent large trial data found a statistically significant effect in the same direction in 19 of 21 cases when the index trial also had a value of P&lt;0.001. <b>Conclusions</b>&nbsp;The frequency of VLEs followed by a large trial is vanishingly small, and where they occur they do not appear to be a reliable marker for a benefit that is reproducible and directly actionable. An empirical rule using a VLE in a randomised controlled trial as a marker that further trials are unnecessary would be neither practical nor useful. Caution should be taken when interpreting small studies with very large treatment effects.
TCT-534 Fractional Flow Reserve and Cardiac Events In Coronary Artery Disease: Data From Prospective Registry
Authors: Jung-Min Ahn, Min Soo Cho, Se Hun Kang, Duk-Woo Park, Eun-Seok Shin, Bon-Kwon Koo, Chang-Wook Nam, Joon Hyung Doh, June Hong Kim, In Ho Chae, Junghan Yoon, Sung-Ho Her, Ki-bae Seung, Woo-Young Chung, Sang-Yong Yoo, Jin Bae Lee, None si wan choi, Kyungil Park, TaekJong Hong, Sang Yeub Lee, Pil Hyung Lee, Soo-Jin Kang, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Seung-Jung Park
Journal: Journal of the American College of Cardiology (2016)
IL-17 Receptor Signaling in Oral Epithelial Cells Is Critical for Protection against Oropharyngeal Candidiasis
Authors: Heather R. Conti, Vincent M. Bruno, Erin E. Childs, Sean Daugherty, Joseph P. Hunter, Bemnet G. Mengesha, Danielle L. Saevig, Matthew R. Hendricks, Bianca M. Coleman, Lucas Brane, Norma Solis, J. Agustin Cruz, Akash H. Verma, Abhishek V. Garg, Amy G. Hise, Jonathan P. Richardson, Julian R. Naglik, Scott G. Filler, Jay K. Kolls, Satrajit Sinha, Sarah L. Gaffen
Journal: Cell Host & Microbe (2016)
TCT-282 Risk Factors Associated with Adverse Events during Chronic Total Occlusion Percutaneous Coronary Interventions: A sub-Analysis of the OPEN-CTO Study
Authors: Robert Riley, James Sapontis, Philip Jones, Ajay Kirtane, Robert Yeh, Dimitri Karmpaliotis, J. Aaron Grantham, William Lombardi, Emmanouil Brilakis, James McCabe
Journal: Journal of the American College of Cardiology (2016)
The components of progression as explanatory variables for overall survival in the RECIST database.
Authors: Saskia Litière, Elisabeth De Vries, Lesley Seymour, Daniel J. Sargent, Lalitha Shankar, Jan Bogaerts
Journal: Journal of Clinical Oncology (2012)

10602 Background: Progressive disease (PD) according to RECIST 1.1 (Eisenhauer et al, 2009) is defined as one or more of (1) PD of measurable target lesions, (2) the presence of a new lesion (NL) or (3) the unequivocal PD of non-target disease (NT-PD). We explored the impact of these components, varying over time, on predicting overall survival (OS) in the RECIST database residing at EORTC (Bogaerts et al, 2009). Methods: Data was selected from 12 randomized clinical trials (3530 patients with breast, lung or colorectal cancer). A maximum of 5 target lesions was used to determine the sum of diameters. The following were calculated or assigned at each measurement time t: best response (BR) was best % improvement from baseline up to t (0% if no improvement - 100% if complete response (CR)); tumor growth (TG) was the weekly rate of increase from nadir to t (0 if no increase; irrespective of prior shrinkage), presence of NL (yes/no), and occurrence of NT-PD (yes/no); categories were not mutually exclusive. OS was analyzed by tumor type using a Cox regression model, adjusting for baseline sum, and including BR, TG, presence of NL and NT-PD as time dependent covariates. Results: Thirty-six percent of patients had NL, 26% had NT-PD, 11% achieved CR and 14% did not have shrinkage of target lesions, while 46% experienced TG (median strongest growth per patient of 0.5 mm/week). Regardless of tumor type, the presence of NL (Hazard Ratio (HR) ranging 1.4-2.5), NT-PD (HR 1.2-2.5) and TG (per 1mm/week increase; HR 1.1-1.4) were associated with worse OS, while achieving CR was associated with a longer OS (HR 0.2-0.8). Further analyses exploring the functional shape of the association between BR and TG, and OS are ongoing. This includes putting TG in contrast with the more usual % cutoff defining target PD. Conclusions: All three components of PD according to RECIST are independently strongly associated with OS. Quantification such as this will enable a better understanding of the role of each component (e.g. clinical aspect of NT-PD assessment) in PD evaluation. Work is ongoing to incorporate this information into an updated RECIST with enhanced prediction of subsequent survival.
HEMOSPRAY EN EL TRATAMIENTO DE LA HEMORRAGIA DIGESTIVA GRAVE EN UN HOSPITAL DE TERCER NIVEL: SERIE DE CASOS
Authors: P Ruiz Bueno, S Álvarez González, Á Terán Lantarón, JI Fortea Ormaechea, MT Arias Loste, Á Puente Sánchez, S Llerena Santiago, MJ García García, PL Fernández Gil, J De La Peña García
Journal: Endoscopy (2016)

Introducción: La hemorragia digestiva grave (alta y baja) se asocia con un pequeño, pero grave, índice de fracaso terapeútico endoscópico, por persistencia o recidiva del sangrado, lo que ha motivado la aparición de nuevos métodos hemostáticos.
TCT-127 Prior Coronary Artery Bypass Graft Surgery and Hemodynamically Supported High Risk Percutaneous Coronary Intervention: Observations from The PROTECT II Randomized Trial and The cVAD Registry
Authors: David Shavelle, Neel Kapasi, Subhash Banerjee, Theodore Schreiber, William O'Neill, Jeffrey J. Popma, Ray Matthews
Journal: Journal of the American College of Cardiology (2016)
P0613 : Hepatitis B core related antigen may be a marker for immune control in HBeAg negative chronic hepatitis B infection
Authors: M.J. Van Campenhout, W.P. Brouwer, H.L Janssen, Q. Xie, Q. Zhang, F. Tabak, A. Streinu-Cercel, J. Wang, G. van Oord, R.J. de Knegt, A. Boonstra, B.E. Hansen
Journal: Journal of Hepatology (2015)
INTERNAL CAROTID ARTERY DISSECTION AND DELAYED STROKE FOLLOWING RUGBY TACKLE – A CASE REPORT
Authors: D Cowlin, M Dickinson, S Sultan
Journal: British Journal of Sports Medicine (2016)

Following England's grand slam success in the ‘Six Nations’ tournament in 2016, publicity around the safety of rugby football is likely to be greater than ever before. Recent media coverage around players that have sustained head injuries in the context of competitive sporting events has also served to increase the awareness amongst sporting management, players and governing bodies alike. Significant head and neck injuries are thankfully rare in all contact sports. However there is always an element of risk when tough physical contact occurs between participants (either intentionally or accidental). The possible consequences of impact injuries, whilst occasional, should not be viewed as an unfortunate exception to the rule but should be used to increase and develop injury/clinical management/training strategies for all sporting levels, not just at the international end of the game. Sporting governing bodies such as the RFU (Rugby football Union) do much to minimise risk, including raising awareness of the consequence of head injuries and secondary impact syndrome, use of concussion scoring tools and removal of players from the field for formal assessment. However, these strategies are usually only utilised when players have sustained a head injury. This case study details a 36 year old male who collapsed 4 hours after competing in a rugby match. After initial diagnostic confusion, it later transpired he had suffered a middle cerebral artery thrombus, secondary to internal carotid artery dissection. This was as a consequence of a collision during a rugby match, and a suspected shearing or deceleration injury due to neck twisting during a tackle. This report will offer a unique and interesting insight into the patient's perspective of this injury – both at the time the actual stroke occurred and his subsequent rehabilitation journey. It will also discuss that whilst much publicity and training is offered around the assessment and management of head injuries and/or concussion, the possible intracerebral consequence of neck trauma sustained in contact sports seems to be less well publicised. This mechanism of injury should be considered in the emergency department as in this case the ‘typical clinical presentation’ of an extradural haematoma turned out to be something quite different.
EFECTIVIDAD, LIMITACIONES Y COMPLICACIONES DE LA CÁPSULA PATENCY EN LA PRÁCTICA DIARIA
Authors: A Cebrián García, I Fernández-Urien, JF Juanmartiñena Fernández, E Macías Mendizabal, C Saldaña Dueñas, JJ Vila Costas
Journal: Endoscopy (2016)

La cápsula endoscópica (CE) se ha convertido en una herramienta de primera linea en el estudio del intestino delgado. Sin embargo, no está exenta de complicaciones, como su retención en casos de estenosis. Para evitarlo, se diseñó la cápsula Patency (CP), que ha demostrado ser muy efectiva en los “trials” iniciales aunque no se dispone de información acerca de su evolución posterior en la práctica diaria.
The Hybrid Algorithm for Treating Chronic Total Occlusions in Europe
Authors: Joren Maeremans, Simon Walsh, Paul Knaapen, James C. Spratt, Alexandre Avran, Colm G. Hanratty, Benjamin Faurie, Pierfrancesco Agostoni, Erwan Bressollette, Peter Kayaert, Alan J. Bagnall, Mohaned Egred, Dave Smith, Alexander Chase, Margaret B. McEntegart, William H.T. Smith, Alun Harcombe, Paul Kelly, John Irving, Elliot J. Smith, Julian W. Strange, Joseph Dens
Journal: Journal of the American College of Cardiology (2016)
TCT-355 Clinical and Angiographic Outcome of Double Crush Versus Provisional-Stenting Technique in Patients With Distal Unprotected Left Main Disease in the Everolimus Eluting Stent Generation Era
Authors: Angela Migliorini, Renato Valenti, Ruben Vergara, Maria Grazia De gregorio, Eleonora Gabrielli, Maria Raffaella Aicale, Elena De Vito, Guido Parodi, Nazzario Carrabba, David Antoniucci
Journal: Journal of the American College of Cardiology (2016)
TCT-246 Cardioscopy-Guided Repair of Aortic Paravalvular Leak in Porcine Beating Heart Model
Authors: Zurab Machaidze, Benoit Rosa, Margherita Mencattelli, Sunil Manjila, Karl Price, Michael Borger, Vinod Thourani, David Brown, Christopher Baird, John Mayer, Pierre Dupont
Journal: Journal of the American College of Cardiology (2016)
PS01.54: Evaluation of Novel Blood-Based Biomarkers with Atezolizumab Monotherapy in 1L Advanced or Metastatic NSCLC (B-F1RST)
Authors: Mark A. Socinski, Joan Schiller, Shaker Dakhil, Shayma Kazmi, Joseph Leach, Sylvia Hu, Sarah M. Paul, David S. Shames, See Phan, Cindy Yun, Vamsidhar Velcheti
Journal: Journal of Thoracic Oncology (2016)
TCT-620 A comparison of clinical outcomes between triple antithrombotic therapy versus dual antiplatelet with left atrial appendage occlusion in patients with atrial fibrillation undergoing drug-eluting stent implantation
Authors: Seung Hun Lee, Jae Young Cho, Hyung Joon Joo, Jae Hyoung Park, Soonjun Hong, Cheol Woong Yu, Do Sun Lim
Journal: Journal of the American College of Cardiology (2016)
TCT-22 Dual Mechanical Support Combining Impella Microaxial Pump and Veno-arterial ECMO Rescues High-risk Patients in Refractory Cardiogenic Shock
Authors: Joern Tongers, Jan-Thorben Sieweke, L Christian Napp, Florian Zauner, Dominik Berliner, Christian Kühn, Axel Haverich, Johann Bauersachs, Andreas Schäfer
Journal: Journal of the American College of Cardiology (2016)
TCT-286 Coronary Artery Spatial Distribution of Chronic Total Occlusions: Insights from a large US Registry
Authors: M. Chadi Alraies, Demetris Yannopoulos, Aris Karatasakis, Dimitrios Karmpaliotis, Khaldoon Alaswad, Farouc Amin Jaffer, Robert Yeh, Mitul Patel, John Bahadorani, Judit Karacsonyi, Aya Alame, Subhash Banerjee, Emmanouil Brilakis, Santiago Garcia
Journal: Journal of the American College of Cardiology (2016)
A Phase II Study of Azacitidine (Vidaza™) for Patients with Myelofibrosis (MF).
Authors: Alfonso Quintas-Cardama, Hagop Kantarjian, Guillermo Garcia-Manero, Deborah Thomas, STeven Kornblau, Elihu Estey, Marilyn Nemri, Jorge Cortes, Francis Giles, Srdan Verstovsek
Journal: Blood (2006)